Syndrome News and Research

RSS

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

UK-based researchers have found that providing clear information and practical or financial support could reduce the number of people who feel that they have to break lockdown rules. They have also evaluated the risk tied to engaging in a particular behavior.

16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

SARS-CoV-2 unique deletion variants found in clinical specimens

While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.

15 Dec 2020

Neanderthal gene variant increases risk of severe COVID-19

Researchers in Germany have conducted a study showing that between 2 and 8% of people in Eurasia carry a genetic variant inherited from Neanderthals that significantly increases the risk of becoming critically ill with coronavirus disease 2019 (COVID-19).

15 Dec 2020

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

A team of US-based researchers recently conducted an illuminating study that explores this method and its potential uses. In doing so, they have underscored the potential utility of wastewater surveillance in managing SARS-CoV-2 outbreaks.

15 Dec 2020

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients.

15 Dec 2020

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

During a Dec. 8 press conference about Operation Warp Speed, President Donald Trump likened the spread of the coronavirus throughout the population — which experts agree bestows some immunity on the people who became ill — to having a COVID-19 vaccine.

15 Dec 2020

Researchers use HACCP framework to assess COVID-19 transmission risks in universities

Using the Hazard Analysis of Critical Control Points (HACCP) framework, researchers assessed the risk and mitigation strategies for universities with students returning to campus. The methodology allowed a rapid response to curb disease transmission with continuing education.

15 Dec 2020

Structural inequalities in Brazil linked to higher COVID-19-related mortality in low-income areas

A team of researchers aimed to determine the differential health effects of COVID-19 on disadvantaged population groups. They found that low-income and Black and Pardo communities in the country are more likely to die from COVID-19.

15 Dec 2020

Environmental monitoring shows SARS-CoV-2 contamination of surfaces in food plants

The COVID-19 pandemic caused by SARS-CoV-2 has presented new challenges to food manufacturers.

15 Dec 2020

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020

UK government declares identification of a “new variant” of coronavirus

The UK government has released a statement that a “new variant” of coronavirus that could be causing a faster spread of the virus has been identified.

15 Dec 2020

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics.

15 Dec 2020

Study: Even minor strokes can diminish neural processing in the brain

After Julia had a minor stroke, she was thankful for receiving rapid treatment and recovering well. But she did notice an unexpected aftereffect as she returned to normal activities.

15 Dec 2020

Hybrid approach reveals details about genes involved in Meier-Gorlin syndrome

Meier-Gorlin syndrome, or MGS, is a rare genetic developmental disorder that causes dwarfism, small ears, a small brain, missing patella and other skeletal abnormalities. In severe cases, MGS results in miscarriages and stillbirths.

14 Dec 2020

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.

14 Dec 2020

The effect of vaccination on the spread of COVID-19 disease

Researchers from Cornell University, USA, have modeled the effect of vaccination on the spread of COVID-19 disease. They suggest that vaccinating healthcare workers first followed by people who have many social interactions, such as grocers and airline cabin crew, will help reduce transmission. The research is published on the preprint server medRxiv*, prior to peer review.

14 Dec 2020

Research shows fitness suffered in most individuals during COVID-19

Researchers from the University of Texas, San Antonio and UT-Health Sciences, Texas, recently attempted to fill this knowledge gap by addressing how the COVID-19 pandemic and related stay-at-home orders are changing the daily habits of individuals.

14 Dec 2020

Quality family time and work flexibility: Australians report unexpected positives to the COVID-19 pandemic

Researchers at the University of Sydney wanted to determine what Australians think are the positive effects brought on by the pandemic.

14 Dec 2020

Syndrome News and Research

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

RedHill Biopharma announces promising preliminary results from opaganib study

SARS-CoV-2 unique deletion variants found in clinical specimens

Neanderthal gene variant increases risk of severe COVID-19

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

Researchers use HACCP framework to assess COVID-19 transmission risks in universities

Structural inequalities in Brazil linked to higher COVID-19-related mortality in low-income areas

Environmental monitoring shows SARS-CoV-2 contamination of surfaces in food plants

Pediatricians want kids to be part of COVID vaccine trials

UK government declares identification of a “new variant” of coronavirus

Reliable Antibodies Testing for SARS-CoV-2

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Study: Even minor strokes can diminish neural processing in the brain

Hybrid approach reveals details about genes involved in Meier-Gorlin syndrome

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

The effect of vaccination on the spread of COVID-19 disease

Research shows fitness suffered in most individuals during COVID-19

Quality family time and work flexibility: Australians report unexpected positives to the COVID-19 pandemic

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News